James Investment Research’s Usana Health Sciences USNA Stock Holding History

James Investment Research’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-72,230	Closed	-$2.82M	–	540
2014 Q2	$2.82M	Sell	72,230 -116,530	-62%	-$4.32M	0.09%	156
2014 Q1	$7.11M	Sell	188,760 -48,270	-20%	-$1.69M	0.23%	115
2013 Q4	$8.96M	Buy	237,030 +31,890	+16%	+$1.22M	0.28%	100
2013 Q3	$8.9M	Buy	205,140 +98,970	+93%	+$3.97M	0.34%	95
2013 Q2	$3.84M	Buy	+106,170	New	+$3.23M	0.16%	120

Other funds holding USNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

James Investment Research's USNA Position: Q3 2014 in Review

James Investment Research sold out of Usana Health Sciences (USNA) in Q3 2014, closing a stake of 72,230 shares — an estimated $2.82M sold.

James Investment Research first reported a position in USNA in Q2 2013 and held it in 5 quarters. The position peaked at $8.96M in Q4 2013. 124 funds tracked by Wall St. Rank hold USNA as of Q3 2014.

James Investment Research reported no remaining Usana Health Sciences position as of Q3 2014 after selling out during the quarter.
James Investment Research sold 72,230 Usana Health Sciences shares in Q3 2014, an estimated $2.82M.
James Investment Research first reported a position in Usana Health Sciences in Q2 2013 and held it in 5 quarters.
James Investment Research's Usana Health Sciences position peaked at $8.96M in Q4 2013.
124 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2014.

Based on James Investment Research's 13F filing for Q3 2014, filed 9 Oct 2014.